HuGE Literature Finder
Records
1
-
25
| Efficacy and potential resistance mechanisms of afatinib in advanced non-small cell lung cancer patients with EGFR G719X/L861Q/S768I. Cancer 2022 Sep . Pang Lan-Lan, Gan Jia-Di, Tan Jia-Rong, Huang Yi-Hua, Liao Jun, Liang Wei-Ting, Deng Peng-Bo, Fang Wen-Fe |
| Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Toxicity and Efficacy in Non-Small-Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e437. He K, Zhang S, Pang J, Yin J, Zhang J, Mu D, Tang S, Li L, Bao H, Wu X, Wang X, Shao Y, Yu J, Yuan |
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
| Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy. Translational lung cancer research 2020 Dec 9 (6): 2367-2379. Xu Yanjun, Li Hui, Huang Zhiyu, Chen Kaiyan, Yu Xiaoqing, Sheng Jiamin, Zhang Han-Han, Fan Y |
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
| Comprehensive Molecular Characterizations of Chinese Patients With Different Subtypes of Lung Squamous Cell Carcinoma. Frontiers in oncology 2020 10 607130. Qian Jie, Chen Rongrong, Zhao Ruiying, Han Yuchen, Yu Yongfe |
| Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of oncology 2020 2020 8811487. Chen Dongfang, Xu Jianlin, Qiao Rong, Zhao Yizhuo, Chu Tianqing, Han Baohui, Zhong Run |
| Impact of Somatic Mutations in Non-Small-Cell Lung Cancer: A Retrospective Study of a Chinese Cohort. Cancer management and research 2020 12 7427-7437. Shen Hai-Bo, Li Jie, Yao Yuan-Shan, Yang Zhen-Hua, Zhou Yin-Jie, Chen Wei, Hu Tian-J |
| Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib. Clinical lung cancer 2018 Sep . Ng Terry L, Yu Hui, Smith Derek E, Boyle Theresa A, York Emily R, Leedy Scott, Gao Dexiang, Aisner Dara L, Van Bokhoven Adrie, Heasley Lynn E, Hirsch Fred R, Camidge D Ro |
| Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance. Lung cancer (Amsterdam, Netherlands) 2018 Jun 120 113-121. Du Meijun, Thompson Jonathan, Fisher Hannah, Zhang Peng, Huang Chiang-Ching, Wang Lia |
| Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment. Oncotarget 2018 May 9 (40): 26195-26208. Jakobsen Jan Nyrop, Santoni-Rugiu Eric, Grauslund Morten, Melchior Linea, Sørensen Jens Be |
| Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients. BMC cancer 2016 Nov 16 (1): 864. Ko Ryo, Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Wakuda Kazushige, Ono Akira, Taira Tetsuhiko, Naito Tateaki, Murakami Haruyasu, Isaka Mitsuhiro, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyuki, Takahashi Kazuhisa, Takahashi Toshia |
| FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib. Cancer science 2016 Sep . Hibi Masaaki, Kaneda Hiroyasu, Tanizaki Junko, Sakai Kazuko, Togashi Yosuke, Terashima Masato, De Velasco Marco Antonio, Fujita Yoshihiko, Banno Eri, Nakamura Yu, Takeda Masayuki, Ito Akihiko, Mitsudomi Tetsuya, Nakagawa Kazuhiko, Okamoto Isamu, Nishio Kazu |
| Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Aug . Miyoshi Tomohiro, Umemura Shigeki, Matsumura Yuki, Mimaki Sachiyo, Tada Satoshi, Ishii Genichiro, Udagawa Hibiki, Matsumoto Shingo, Yoh Kiyotaka, Niho Seiji, Ohmatsu Hironobu, Aokage Keiju, Hishida Tomoyuki, Yoshida Junji, Nagai Kanji, Goto Koichi, Tsuboi Masahiro, Tsuchihara Katsu |
| Clinical correlation of extensive-stage small-cell lung cancer genomics. Annals of oncology : official journal of the European Society for Medical Oncology 2016 Apr 27 (4): 642-7. Dowlati A, Lipka M B, McColl K, Dabir S, Behtaj M, Kresak A, Miron A, Yang M, Sharma N, Fu P, Wildey |
| Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma. European journal of cancer (Oxford, England : 1990) 2016 Feb 57 91-103. Yang Ching-Yao, Lin Mong-Wei, Chang Yih-Leong, Wu Chen-Tu, Yang Pan-Ch |
| FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer. Virchows Archiv : an international journal of pathology 2014 Nov 465 (5): 547-58. Seo An Na, Jin Yan, Lee Hee Jin, Sun Ping-Li, Kim Hyojin, Jheon Sanghoon, Kim Kwhanmien, Lee Choon-Taek, Chung Jin-Hae |
| FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 20 (12): 3299-309. Wynes Murry W, Hinz Trista K, Gao Dexiang, Martini Michael, Marek Lindsay A, Ware Kathryn E, Edwards Michael G, Böhm Diana, Perner Sven, Helfrich Barbara A, Dziadziuszko Rafal, Jassem Jacek, Wojtylak Szymon, Sejda Aleksandra, Gozgit Joseph M, Bunn Paul A, Camidge D Ross, Tan Aik-Choon, Hirsch Fred R, Heasley Lynn |
| Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute study. Cancer 2014 May 120 (10): 1471-81. Serizawa Masakuni, Koh Yasuhiro, Kenmotsu Hirotsugu, Isaka Mitsuhiro, Murakami Haruyasu, Akamatsu Hiroaki, Mori Keita, Abe Masato, Hayashi Isamu, Taira Tetsuhiko, Maniwa Tomohiro, Takahashi Toshiaki, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyu |
| Molecular profiling of small cell lung cancer in a Japanese cohort. Lung cancer (Amsterdam, Netherlands) 2014 May 84 (2): 139-44. Wakuda Kazushige, Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Isaka Mitsuhiro, Takahashi Shoji, Ono Akira, Taira Tetsuhiko, Naito Tateaki, Murakami Haruyasu, Mori Keita, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Takahashi Toshiaki, Yamamoto Nobuyu |
| Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease. PloS one 2014 9 (4): e95303. Toschi Luca, Finocchiaro Giovanna, Nguyen Teresa T, Skokan Margaret C, Giordano Laura, Gianoncelli Letizia, Perrino Matteo, Siracusano Licia, Di Tommaso Luca, Infante Maurizio, Alloisio Marco, Roncalli Massimo, Scorsetti Marta, Jänne Pasi A, Santoro Armando, Varella-Garcia Marilei |
| Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays. BMC cancer 2014 14 786. Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Isaka Mitsuhiro, Takahashi Toshiaki, Taira Tetsuhiko, Ono Akira, Maniwa Tomohiro, Takahashi Shoji, Mori Keita, Endo Masahiro, Abe Masato, Hayashi Isamu, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyu |
| Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2013 Sep 81 (3): 462-7. Tran Thang N, Selinger Christina I, Kohonen-Corish Maija R J, McCaughan Brian C, Kennedy Catherine W, O'Toole Sandra A, Cooper Wendy |
| A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013 Jan 8 (1): 79-88. Dy Grace K, Mandrekar Sumithra J, Nelson Garth D, Meyers Jeffrey P, Adjei Araba A, Ross Helen J, Ansari Rafat H, Lyss Alan P, Stella Philip J, Schild Steven E, Molina Julian R, Adjei Alex |
| Increased FGFR1 copy number in lung squamous cell carcinomas. Molecular medicine reports 2012 Mar 5 (3): 725-8. Sasaki Hidefumi, Shitara Masayuki, Yokota Keisuke, Hikosaka Yu, Moriyama Satoru, Yano Motoki, Fujii Yoshita |
- Page last reviewed:Jul 25, 2022
- Page last updated:Dec 05, 2022
- Content source: